Drugs / Madecassoside
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT07606703 | Sep 2025 → Mar 2028 expected | chronic graft versus host disease | WeiShi | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Madecassoside | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07606703 ↗ |
| Route | Oral | “administered orally” NCT07606703 ↗ |